查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
CRISPR和Cas基因市场规模,份额和趋势分析报告：按用户（CRO,生物技术和製药）,应用（生物医学,农业）,产品和服务,地区细分市场预测2022-2030
市场调查报告书
商品编码
1147491

CRISPR和Cas基因市场规模,份额和趋势分析报告：按用户（CRO,生物技术和製药）,应用（生物医学,农业）,产品和服务,地区细分市场预测2022-2030

CRISPR And Cas Genes Market Size, Share & Trends Analysis Report By End-use (CROs, Biotech & Pharma Companies), By Application (Biomedical, Agriculture), By Product & Service, By Region, And Segment Forecasts, 2022 - 2030
出版日期: | 出版商: Grand View Research | 英文 170 Pages | 商品交期: 2-10个工作天内

价格

CRISPR 和 Cas 基因的市场增长和趋势

根据 Grand View Research, Inc. 的最新报告，到 2030 年，全球 CRISPR 和 Cas 基因市场规模预计将达到 96 亿美元。由于 CRISPR 和 Cas 基因係统在生物医学研究领域的应用越来越广泛，预计该市场在预测期内的复合年增长率将达到 17.9%。基因组编辑领域的进步大大增加了 CRISPR-Cas 系统在原核诊断和进化分析评估中的使用。该技术的应用使得基因编辑变得容易且成本低成为可能。基因组编辑极大地推进了生物医学研究，当前最先进的趋势为未来治疗各种遗传和非遗传疾病铺平了道路。

CRISPR/Cas9 介导的基因和基因组编辑技术的使用促进了更有效的基因打靶方法的开发和实施以及基因编辑鸟类的培育。根据 2021 年 2 月发表在 Frontiers 上的一篇论文，CRISPR/Cas9 已成为家禽业基因编辑的强大而重要的工具。多个领域的潜在应用将进一步推动对该技术的需求。 COVID-19 的爆发已将研究人员的注意力转移到开发基于该技术的 COVID-19 分子诊断工具上。例如，2021 年 3 月，新加坡南洋理工大学的研究人员创建了一种基于 CRISPR 的 COVID-19 测试，可在 30 分钟内得出结果。

即使病毒已经变异，这个测试也会发现它。这将进一步鼓励其他主要参与者利用这项技术，从而推动行业增长。这项技术越来越多地用于医疗和其他应用。随着越来越多的学术机构和生物技术公司寻求为该技术开发新的商业应用，预计此类基因编辑技术的专利竞争将会加剧。此外，该技术有可能通过使用机器学习技术进一步发展。例如，2022 年 8 月，Synthego 将提供工程细胞库，这是一项扩大 CRISPR 访问的尖端服务，提供 CRISPR 编辑的细胞阵列，可直接用于功能筛选实验。

有望应用于疾病研究。领先企业为基因编辑工作流程的每一步提供工具和解决方案。通过集成多种工具、服务和改进的流程，可以更快、更轻鬆地完成研究实验。此外，主要参与者已经筹集了大量资金来支持 CRISPR 和 Cas9 基因编辑方法的研发。例如，2021 年 4 月，Vertex Pharmaceuticals 与 CRISPR Therapeutics 合作开发和製造 CTX001，这是一种基于 CRISPR/Cas9 的新型基因编辑疗法，可能成为输血依赖性Beta-地中海贫血和镰状细胞病 (SCD) 的治疗选择.宣布它将2020 年 1 月，Mammoth Biosciences 筹集了 4500 万美元用于开发用于治疗和诊断目的的下一代 CRISPR 产品。它还将用于开发公司的 CRISPR 基因驱动诊断产品组合。

CRISPR 和 Cas 基因市场报告要点

在产品和服务方面，由于广泛的产品组合的可用性以及越来越多的最终用户采用，该产品领域在 2021 年占据了行业主导地位。

生物医药领域将在 2021 年主导该行业。利用先进的基因组编辑技术进行的广泛研究和研究数量的显着增加促进了细分市场的增长

生物技术和製药公司的最终用途部分将在 2021 年占据主要收入份额。主要参与者正在采用该技术来创建人类疾病的生物学模型，并进一步加速新治疗靶点的识别

由于多家製药巨头的存在、研究资金的增加、研究批准的高水平以及对新疗法的需求，北美将在 2021 年获得最高的收入份额。

内容

第 1 章调查方法及范围

  • 市场细分和范围
    • 区域范围
  • 调查方法
  • 资讯采购
    • 购买的数据库
    • GVR 内部数据库
    • 次要资讯
    • 初步调查
  • 资讯或数据分析
    • 数据分析模型
  • 市场製定和验证
  • 模型详细资讯
    • 商品流分析（模型 1）
      • 方法 1：商品流方法
  • 调查假设
  • 计算市场份额
  • 次要资讯列表
  • 缩写列表
  • 目的

第 2 章执行摘要

  • 市场概览

第 3 章 CRISPR 和 Cas 基因市场变量、趋势和范围

  • 市场细分和范围
  • 市场促进因素分析
    • 对新疗法的需求不断增长
    • 对基因编辑的需求不断增长
    • 癌症发病率增加
  • 市场抑制因素分析
    • Crispr 技术的脱靶效应
    • 高成本因素、知识产权纠纷、道德困境
  • Crispr 和 Cas 基因市场 Swot 分析，按因素（政治和法律、经济和技术）
  • 行业分析 - 波特

第 4 章产品和服务的业务分析

  • CRISPR 和 Cas 基因市场：产品和服务的差异分析
    • 按产品分类
      • 试剂盒和□
      • 基于载体的 Cas9
      • 无 DNA Cas9
      • 函式库
      • 设计工具
      • 抗体
      • 其他
    • 按服务
      • 细胞系工程
      • gRNA 设计
      • 微生物基因编辑
      • DNA合成

第 5 章应用业务分析

  • CRISPR 和 Cas 基因市场：应用差异分析
    • 生物医学
      • 基因组工程
      • 疾病模型研究
      • 功能基因组学
      • 表观遗传学
      • 其他
    • 农业

第 6 章最终用途业务分析

  • CRISPR 和 Cas 基因市场：最终用途变异分析
    • 生物技术和製药公司
    • 学术机构和政府研究机构
    • 委託研究组织 (Cros)

第 7 章市场分类：按产品、应用和最终用途分类的区域估计和趋势分析

  • 区域市场概况
  • SWOT 分析，按因素（政治和法律、经济和技术）
    • 北美
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲
  • 2021-2030 年市场规模、预测、趋势分析
  • 北美
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 意大利
    • 西班牙
  • 亚太地区
    • 日本
    • 中国
    • 韩国
    • 印度
  • 拉丁美洲
    • 巴西
    • 墨西哥
  • 中东和非洲 (MEA)
    • 南非
    • 沙特阿拉伯

第 8 章竞争格局

  • 顶级 CRISPR 创新者及其研究重点
  • 战略框架
  • 市场进入者分类
  • 公司简介
    • CARIBOU BIOSCIENCES
      • 公司简介
      • 财务业绩
      • 产品基准
      • 战略举措
    • ASTRAZENECA
      • 公司简介
      • 财务业绩
      • 产品基准
      • 战略举措
    • INTELLIA THERAPEUTICS, INC.
      • 公司简介
      • 财务业绩
      • 产品基准
      • 战略举措
    • ADDGENE
      • 公司简介
      • 财务业绩
      • 产品基准
    • CRISPR THERAPEUTICS
      • 公司简介
      • 财务业绩
      • 产品基准
      • 战略举措
    • NEW ENGLAND BIOLABS
      • 公司简介
      • 财务业绩
      • 产品基准
      • 战略举措
    • Thermo Fisher Scientific, Inc.
      • 公司简介
      • 财务业绩
      • 产品基准
      • 战略举措
    • SYNTHEGO
      • 公司简介
      • 财务业绩
      • 产品基准
      • 战略举措
    • MAMMOTH BIOSCIENCES
      • 公司简介
      • 财务业绩
      • 产品基准
      • 战略举措
    • INSCRIPTA, INC.
      • 公司简介
      • 财务业绩
      • 产品基准
      • 战略举措
    • CIBUS
      • 公司简介
      • 财务业绩
      • 产品基准
      • 战略举措
    • BEAM THERAPEUTICS
      • 公司简介
      • 财务业绩
      • 产品基准
      • 战略举措
    • PLANTEDIT
      • 公司简介
      • 产品基准
    • VERTEX PHARMACEUTICALS INCORPORATED
      • 公司简介
      • 财务业绩
      • 产品基准
      • 战略举措
    • GENSCRIPT
      • 公司简介
      • 财务业绩
      • 产品基准
      • 战略举措
    • INTEGRATED DNA TECHNOLOGIES
      • 公司简介
      • 财务业绩
      • 产品基准
      • 战略举措
    • LONZA
      • 公司简介
      • 财务业绩
      • 产品基准
      • 战略举措
    • MERCK
      • 公司简介
      • 财务业绩
      • 产品基准
      • 战略举措
    • HERA BIOLABS
      • 公司简介
      • 产品基准
      • 战略举措
    • ORIGENE TECHNOLOGIES, INC.
      • 公司简介
      • 财务业绩
      • 产品基准
    • RECOMBINETICS, INC.
      • 公司简介
      • 财务业绩
      • 产品基准
      • 战略举措
Product Code: GVR-1-68038-375-1

CRISPR And Cas Genes Market Growth & Trends:

The global CRISPR and Cas genes market size is expected to reach USD 9.6 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to register a CAGR of 17.9% during the forecast period, owing to the increasing usage of CRISPR and Cas genes systems in the biomedical research field. The use of CRISPR-Cas systems in diagnostics and the assessment of evolutionary analysis in prokaryotes has significantly increased, owing to the developments in the field of genome editing. The application of this technology enables easy and cost-efficient editing of genes. Genome editing has made a significant advancement in biomedical research, with the present trend of cutting-edge techniques paving the way for the future treatment of different genetic and non-genetic disorders.

The development and implementation of more effective ways for gene targeting and the generation of gene-edited avian species have been facilitated by the availability of the CRISPR/Cas9-mediated gene and genome editing technology. According to an article published on Frontiers in February 2021, CRISPR/Cas9 has become a robust and important tool for gene editing in the poultry industry. Potential applications in several fields would further boost the demand for this technology. The COVID-19 outbreak shifted the researcher's emphasis to the development of COVID-19 molecular diagnostic tools based on this technology. For instance, in March 2021, Nanyang Technological University researchers in Singapore created a COVID-19 test based on CRISPR that provides results in 30 minutes.

Even after the virus has mutated, this test still discovers it. This would further encourage the other key players to leverage this technique, thereby driving the industry's growth. This technology is increasingly being used for several medical and other applications. Competition over patents for such a gene-editing technology is expected to grow, as more academic institutions and biotech companies attempt to develop new commercial applications of this technology. In addition, there is a lot of potential for this technique to advance with the use of machine learning technologies. For instance, in August 2022, Synthego launched engineered cell libraries, a cutting-edge service that expands access to CRISPR by giving arrayed CRISPR-edited cells for use directly in functional screening experiments.

It has potential applications in disease research. Key players offer tools and solutions for each step of the gene editing workflow. Integrating several tools, services, and improved processes makes it possible to complete research experiments rapidly and with little effort. Moreover, key players have raised significant funding to support the R&D of the CRISPR & Cas9 gene-editing approach. For instance, in April 2021, Vertex Pharmaceuticals collaborated with CRISPR Therapeutics to develop and manufacture a new CRISPR/Cas9-based gene editing therapy called CTX001, a potential therapeutic option for transfusion-dependent beta-thalassemia and Sickle Cell Disease (SCD). In January 2020, Mammoth Biosciences raised USD 45 million to develop next-gen CRISPR products for therapeutics & diagnostics purposes. This would further be used to develop the company's CRISPR genes-driven diagnostics portfolio.

CRISPR And Cas Genes Market Report Highlights:

  • By product and services, the product segment dominated the industry in 2021 due to the availability of a broad range of product portfolios & rising adoption by various end-users
  • The biomedical segment dominated the industry in 2021. Extensive research and a significant rise in the number of research studies utilizing the advanced technique for genome editing have contributed to the segment growth
  • The biotechnology & pharmaceutical companies end-use segment captured the major revenue share in 2021. Key players are adopting this technology to produce biological models for human diseases and further accelerate new therapeutic target identification
  • North America captured the highest revenue share in 2021 owing to the presence of several pharmaceutical giants, increased research funding, a high number of research approvals, and the need for novel therapeutics

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market Segmentation and Scope
    • 1.1.1 Regional Scope
    • 1.1.2 Estimates And Forecast Timeline
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased Database
    • 1.3.2 GVR's Internal Database
    • 1.3.3 Secondary Sources
    • 1.3.4 Primary Research
  • 1.4 Information Or Data Analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Commodity Flow Analysis (Model 1)
      • 1.6.1.1 Approach 1: Commodity Flow Approach
  • 1.7 Research Assumptions
  • 1.8 Market Share Calculations
  • 1.9 List Of Secondary Sources
  • 1.10 List Of Abbreviations
  • 1.11 Objectives
    • 1.11.1 Objective 1
    • 1.11.2 Objective 2
    • 1.11.3 Objective 3
    • 1.11.4 Objective 4

Chapter 2 Executive Summary

  • 2.1 Market Summary

Chapter 3 Crispr & Cas Genes Market Variables, Trends And Scope

  • 3.1 Market Segmentation & Scope
  • 3.2 Market Driver Analysis
    • 3.2.1 Growing Need For Novel Therapeutics
    • 3.2.2 Rising Demand For Gene Editing
    • 3.3.3 Rising Incidence Of Cancer
  • 3.3 Market Restraint Analysis
    • 3.3.1 Off-Target Effects Of Crispr Technology
    • 3.3.2 High-Cost Factor, Intellectual Property Disputes & Ethical Dilemma
  • 3.4 Crispr & Cas Genes Market-Swot Analysis, By Factor (Political & Legal, Economic And Technological)
  • 3.5 Industry Analysis - Porter's

Chapter 4 Product & Service Business Analysis

  • 4.1 Crispr And Cas Genes Market: Product & Service Movement Analysis
    • 4.1.1 By Product
      • 4.1.1.1 Global Crispr And Cas Genes Products Market, 2018 - 2030 (USD Million)
      • 4.1.1.2 Kits & Enzymes
      • 4.1.1.2.1 Global Crispr And Cas Genes Kits And Enzymes Market, 2018 - 2030 (USD Million)
      • 4.1.1.2.2 Vector-Based Cas9
      • 4.1.1.2.2.1 Global Vector-Based Crispr And Cas Genes Market, 2018 - 2030 (USD Million)
      • 4.1.1.2.3 Dna-Free Cas9
      • 4.1.1.2.3.1 Global Dna-Free Crispr And Cas Genes Market, 2018 - 2030 (USD Million)
      • 4.1.1.3 Libraries
      • 4.1.1.3.1 Global Crispr And Cas Genes Libraries Market, 2018 - 2030 (USD Million)
      • 4.1.1.4 Design Tools
      • 4.1.1.4.1 Global Crispr And Cas Genes Design Tool Market, 2018 - 2030 (USD Million)
      • 4.1.1.5 Antibodies
      • 4.1.1.5.1 Global Crispr And Cas Genes Antibodies Market, 2018 - 2030 (USD Million)
      • 4.1.1.6 Others
      • 4.1.1.6.1 Global Crispr And Cas Genes Market For Others, 2018 - 2030 (USD Million)
    • 4.1.2 By Service
      • 4.1.2.1 Global Crispr And Cas Genes Service Market, 2018 - 2030 (USD Million)
      • 4.1.2.2 Cell Line Engineering
      • 4.1.2.2.1 Global Cell Engineering Services Market, 2018 - 2030 (USD Million)
      • 4.1.2.3 gRNA Design
      • 4.1.2.3.1 Global gRNA Design Market, 2018 - 2030 (USD Million)
      • 4.1.2.4 Microbial Gene Editing
      • 4.1.2.4.1 Global Microbial Gene Editing Market, 2018 - 2030 (USD Million)
      • 4.1.2.5 Dna Synthesis
      • 4.1.2.5.1 Global Dna Synthesis Market, 2018 - 2030 (USD Million)

Chapter 5 Application Business Analysis

  • 5.1 Crispr And Cas Genes Market: Application Movement Analysis
    • 5.1.1 Biomedical
      • 5.1.1.1 Global Crispr And Cas Genes Market For Biomedical, 2018 - 2030 (USD Million)
      • 5.1.1.2 Genome Engineering
      • 5.1.1.2.1 Global Crispr And Cas Genes Market For Genome Engineering, 2018 - 2030 (USD Million)
      • 5.1.1.3 Disease Model Studies
      • 5.1.1.3.1 Global Crispr And Cas Genes Market For Disease Model Studies, 2018 - 2030 (USD Million)
      • 5.1.1.4 Functional Genomics
      • 5.1.1.4.1 Global Crispr And Cas Genes Market For Functional Genomics, 2018 - 2030 (USD Million)
      • 5.1.1.5 Epigenetics
      • 5.1.1.5.1 Global Crispr And Cas Genes Market For Epigenetics, 2018 - 2030 (USD Million)
      • 5.1.1.6 Others
      • 5.1.1.6.1 Global Crispr And Cas Genes Market For Others, 2018 - 2030 (USD Million)
    • 5.1.2 Agriculture
      • 5.1.2.1 Global Crispr And Cas Genes Market For Agriculture, 2018 - 2030 (USD Million)

Chapter 6 End-Use Business Analysis

  • 6.1 Crispr And Cas Genes Market: End-Use Movement Analysis
    • 6.1.1 Biotechnology & Pharmaceutical Companies
      • 6.1.1.1 Global Crispr And Cas Genes Market For Biotechnology & Pharmaceutical Companies, 2018 - 2030 (USD Million)
    • 6.1.2 Academics & Government Research Institutes
      • 6.1.2.1 Global Crispr And Cas Genes Market For Academics & Government Research Institutes, 2018 - 2030 (USD Million)
    • 6.1.3 Contract Research Organizations (Cros)
      • 6.1.3.1 Global Crispr And Cas Genes Market For Contract Research Organizations (Cros), 2018 - 2030 (USD Million)

Chapter 7 Market Categorization: Regional Estimates & Trend Analysis by Product, Application & End-use

  • 7.1 Regional Market Snapshot
  • 7.2 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
    • 7.2.1 North America
    • 7.2.2 Europe
    • 7.2.3 Asia Pacific
    • 7.2.4 Latin America
    • 7.2.5 Middle East And Africa
  • 7.3 Market Size, & Forecasts, Trend Analysis, 2021 to 2030
  • 7.4 North America
    • 7.4.1 North America CRISPR And Cas Genes Market Estimates And Forecast, 2018-2030, (USD Billion)
    • 7.4.2 U.S.
      • 7.4.2.1 U.S. CRISPR & Cas Gene Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 7.4.3 Canada
      • 7.4.3.1 Canada CRISPR & Cas Genes Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
  • 7.5 Europe
    • 7.5.1 Europe CRISPR And Cas Genes Market Estimates And Forecast, 2018-2030, (USD Billion)
    • 7.5.2 Germany
      • 7.5.2.1 Germany CRISPR & Cas Gene Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 7.5.3 U.K.
      • 7.5.3.1 U.K. CRISPR And Cas Genes Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 7.5.4 France
      • 7.5.4.1 France CRISPR And Cas Genes Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 7.5.5 Italy
      • 7.5.5.1 Italy CRISPR And Cas Genes Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 7.5.6 Spain
      • 7.5.6.1 Spain CRISPR And Cas Genes Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 7.6 Asia Pacific
    • 7.6.1 Asia Pacific CRISPR And Cas Genes Market Estimates And Forecast, 2018-2030, (USD Billion)
    • 7.6.2 Japan
      • 7.6.2.1 Japan CRISPR & Cas Genes Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 7.6.3 China
      • 7.6.3.1 China CRISPR And Cas Genes Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 7.6.4 South Korea
      • 7.6.4.1 South Korea CRISPR And Cas Genes Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 7.6.5 India
      • 7.6.5.1 India CRISPR And Cas Genes Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 7.7 Latin America
    • 7.7.1 Latin America CRISPR And Cas Genes Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 7.7.2 Brazil
      • 7.7.2.1 Brazil CRISPR And Cas Genes Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 7.7.3 Mexico
      • 7.7.3.1 Mexico CRISPR And Cas Genes Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 7.8 Middle East & Africa (Mea)
    • 7.8.1 MEA CRISPR And Cas Genes Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 7.8.2 South Africa
      • 7.8.2.1 South Africa CRISPR And Cas Genes Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 7.8.3 Saudi Arabia
      • 7.8.3.1 Saudi Arabia CRISPR And Cas Genes Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 8 Competitive Landscape

  • 8.1 Top CRISPR Innovators and Their Research Focus
  • 8.2 Strategy Framework
  • 8.3 Market Participant Categorization
  • 8.4 Company Profiles
    • 8.4.1 CARIBOU BIOSCIENCES
      • 8.4.1.1 Company Overview
      • 8.4.1.2 Financial Performance
      • 8.4.1.3 Product Benchmarking
      • 8.4.1.4 Strategic Initiatives
    • 8.4.2 ASTRAZENECA
      • 8.4.2.1 Company Overview
      • 8.4.2.2 Financial Performance
      • 8.4.2.3 Product Benchmarking
      • 8.4.2.4 Strategic Initiatives
    • 8.4.3 INTELLIA THERAPEUTICS, INC.
      • 8.4.3.1 Company Overview
      • 8.4.3.2 Financial Performance
      • 8.4.3.3 Product Benchmarking
      • 8.4.3.4 Strategic Initiatives
    • 8.4.4 ADDGENE
      • 8.4.4.1 Company Overview
      • 8.4.4.2 Financial Performance
      • 8.4.4.3 Product Benchmarking
    • 8.4.5 CRISPR THERAPEUTICS
      • 8.4.5.1 Company Overview
      • 8.4.5.2 Financial Performance
      • 8.4.5.3 Product Benchmarking
      • 8.4.5.4 Strategic Initiatives
    • 8.4.6 NEW ENGLAND BIOLABS
      • 8.4.6.1 Company Overview
      • 8.4.6.2 Financial Performance
      • 8.4.6.3 Product Benchmarking
      • 8.4.6.4 Strategic Initiatives
    • 8.4.7 THERMO FISHER SCIENTIFIC, INC.
      • 8.4.7.1 Company Overview
      • 8.4.7.2 Financial Performance
      • 8.4.7.3 Product Benchmarking
      • 8.4.7.4 Strategic Initiatives
    • 8.4.8 SYNTHEGO
      • 8.4.8.1 Company Overview
      • 8.4.8.2 Financial Performance
      • 8.4.8.3 Product Benchmarking
      • 8.4.8.4 Strategic Initiatives
    • 8.4.9 MAMMOTH BIOSCIENCES
      • 8.4.9.1 Company Overview
      • 8.4.9.2 Financial Performance
      • 8.4.9.3 Product Benchmarking
      • 8.4.9.4 Strategic Initiatives
    • 8.4.10 INSCRIPTA, INC.
      • 8.4.10.1 Company Overview
      • 8.4.10.2 Financial Performance
      • 8.4.10.3 Product Benchmarking
      • 8.4.10.4 Strategic Initiatives
    • 8.4.11 CIBUS
      • 8.4.11.1 Company Overview
      • 8.4.11.2 Financial Performance
      • 8.4.11.3 Product Benchmarking
      • 8.4.11.4 Strategic Initiatives
    • 8.4.12 BEAM THERAPEUTICS
      • 8.4.12.1 Company Overview
      • 8.4.12.2 Financial Performance
      • 8.4.12.3 Product Benchmarking
      • 8.4.12.4 Strategic Initiatives
    • 8.4.13 PLANTEDIT
      • 8.4.13.1 Company Overview
      • 8.4.13.2 Product Benchmarking
    • 8.4.14 VERTEX PHARMACEUTICALS INCORPORATED
      • 8.4.14.1 Company Overview
      • 8.4.14.2 Financial Performance
      • 8.4.14.3 Product Benchmarking
      • 8.4.14.4 Strategic Initiatives
    • 8.4.15 GENSCRIPT
      • 8.4.15.1 Company Overview
      • 8.4.15.2 Financial Performance
      • 8.4.15.3 Product Benchmarking
      • 8.4.15.4 Strategic Initiatives
    • 8.4.16 INTEGRATED DNA TECHNOLOGIES
      • 8.4.16.1 Company Overview
      • 8.4.16.2 Financial Performance
      • 8.4.16.3 Product Benchmarking
      • 8.4.16.4 Strategic Initiatives
    • 8.4.17 LONZA
      • 8.4.17.1 Company Overview
      • 8.4.17.2 Financial Performance
      • 8.4.17.3 Product Benchmarking
      • 8.4.17.4 Strategic Initiatives
    • 8.4.18 MERCK
      • 8.4.18.1 Company Overview
      • 8.4.18.2 Financial Performance
      • 8.4.18.3 Product Benchmarking
      • 8.4.18.4 Strategic Initiatives
    • 8.4.19 HERA BIOLABS
      • 8.4.19.1 Company Overview
      • 8.4.19.2 Product Benchmarking
      • 8.4.19.3 Strategic Initiatives
    • 8.4.20 ORIGENE TECHNOLOGIES, INC.
      • 8.4.20.1 Company Overview
      • 8.4.20.2 Financial Performance
      • 8.4.20.3 Product Benchmarking
    • 8.4.21 RECOMBINETICS, INC.
      • 8.4.21.1 Company Overview
      • 8.4.21.2 Financial Performance
      • 8.4.21.3 Product Benchmarking
      • 8.4.21.4 Strategic Initiative

List of Tables

  • Table 1 List of Tables
  • Table 2 List of Secondary Sources
  • Table 3 List of Abbreviations
  • Table 4 Global CRISPR and Cas Genes Market, by Product and Service, 2018 - 2030 (USD Million)
  • Table 5 Global CRISPR and Cas Genes Market, by Application, 2018 - 2030 (USD Million)
  • Table 6 Global CRISPR and Cas Genes Market, by End-use, 2018 - 2030 (USD Million)
  • Table 7 Global CRISPR and Cas Genes Market, by Region, 2018 - 2030 (USD Million)
  • Table 8 North America CRISPR and Cas Genes Market, by Country, 2018 - 2030 (USD Million)
  • Table 9 North America CRISPR and Cas Genes Market, by Product and Service, 2018 - 2030 (USD Million)
  • Table 10 North America CRISPR and Cas Genes Market, by Application, 2018 - 2030 (USD Million)
  • Table 11 North America CRISPR and Cas Genes Market, by End-use, 2018 - 2030 (USD Million)
  • Table 12 U.S. CRISPR and Cas Genes Market, by Product and Service, 2018 - 2030 (USD Million)
  • Table 13 U.S. CRISPR and Cas Genes Market, by Application, 2018 - 2030 (USD Million)
  • Table 14 U.S. CRISPR and Cas Genes Market, by End-use, 2018 - 2030 (USD Million)
  • Table 15 Canada CRISPR and Cas Genes Market, by Product and Service, 2018 - 2030 (USD Million)
  • Table 16 Canada CRISPR and Cas Genes Market, by Application, 2018 - 2030 (USD Million)
  • Table 17 Canada CRISPR and Cas Genes Market, by End-use, 2018 - 2030 (USD Million)
  • Table 18 Europe CRISPR and Cas Genes Market, by Country, 2018 - 2030 (USD Million)
  • Table 19 Europe CRISPR and Cas Genes Market, by Product and Service, 2018 - 2030 (USD Million)
  • Table 20 Europe CRISPR and Cas Genes Market, by Application, 2018 - 2030 (USD Million)
  • Table 21 Europe CRISPR and Cas Genes Market, by End-use, 2018 - 2030 (USD Million)
  • Table 22 Germany CRISPR and Cas Genes Market, by Product and Service, 2018 - 2030 (USD Million)
  • Table 23 Germany CRISPR and Cas Genes Market, by Application, 2018 - 2030 (USD Million)
  • Table 24 Germany CRISPR and Cas Genes Market, by End-use, 2018 - 2030 (USD Million)
  • Table 25 U.K. CRISPR and Cas Genes Market, by Product and Service, 2018 - 2030 (USD Million)
  • Table 26 U.K. CRISPR and Cas Genes Market, by Application, 2018 - 2030 (USD Million)
  • Table 27 U.K. CRISPR and Cas Genes Market, by End-use, 2018 - 2030 (USD Million)
  • Table 28 France CRISPR and Cas Genes Market, by Product and Service, 2018 - 2030 (USD Million)
  • Table 29 France CRISPR and Cas Genes Market, by Application, 2018 - 2030 (USD Million)
  • Table 30 France CRISPR and Cas Genes Market, by End-use, 2018 - 2030 (USD Million)
  • Table 31 Italy CRISPR and Cas Genes Market, by Product and Service, 2018 - 2030 (USD Million)
  • Table 32 Italy CRISPR and Cas Genes Market, by Application, 2018 - 2030 (USD Million)
  • Table 33 Italy CRISPR and Cas Genes Market, by End-use, 2018 - 2030 (USD Million)
  • Table 34 Spain CRISPR and Cas Genes Market, by Product and Service, 2018 - 2030 (USD Million)
  • Table 35 Spain CRISPR and Cas Genes Market, by Application, 2018 - 2030 (USD Million)
  • Table 36 Spain CRISPR and Cas Genes Market, by End-use, 2018 - 2030 (USD Million)
  • Table 37 Asia Pacific CRISPR and Cas Genes Market, by Country, 2018 - 2030 (USD Million)
  • Table 38 Asia Pacific CRISPR and Cas Genes Market, by Product and Service, 2018 - 2030 (USD Million)
  • Table 39 Asia Pacific CRISPR and Cas Genes Market, by Application, 2018 - 2030 (USD Million)
  • Table 40 Asia Pacific CRISPR and Cas Genes Market, by End-use, 2018 - 2030 (USD Million)
  • Table 41 China CRISPR and Cas Genes Market, by Product and Service, 2018 - 2030 (USD Million)
  • Table 42 China CRISPR and Cas Genes Market, by Application, 2018 - 2030 (USD Million)
  • Table 43 China CRISPR and Cas Genes Market, by End-use, 2018 - 2030 (USD Million)
  • Table 44 Japan CRISPR and Cas Genes Market, by Product and Service, 2018 - 2030 (USD Million)
  • Table 45 Japan CRISPR and Cas Genes Market, by Application, 2018 - 2030 (USD Million)
  • Table 46 Japan CRISPR and Cas Genes Market, by End-use, 2018 - 2030 (USD Million)
  • Table 47 India CRISPR and Cas Genes Market, by Product and Service, 2018 - 2030 (USD Million)
  • Table 48 India CRISPR and Cas Genes Market, by Application, 2018 - 2030 (USD Million)
  • Table 49 India CRISPR and Cas Genes Market, by End-use, 2018 - 2030 (USD Million)
  • Table 50 South Korea CRISPR and Cas Genes Market, by Product and Service, 2018 - 2030 (USD Million)
  • Table 51 South Korea CRISPR and Cas Genes Market, by Application, 2018 - 2030 (USD Million)
  • Table 52 South Korea CRISPR and Cas Genes Market, by End-use, 2018 - 2030 (USD Million)
  • Table 53 Latin America CRISPR and Cas Genes Market, by Country, 2018 - 2030 (USD Million)
  • Table 54 Latin America CRISPR and Cas Genes Market, by Product and Service, 2018 - 2030 (USD Million)
  • Table 55 Latin America CRISPR and Cas Genes Market, by Application, 2018 - 2030 (USD Million)
  • Table 56 Latin America CRISPR and Cas Genes Market, by End-use, 2018 - 2030 (USD Million)
  • Table 57 Brazil CRISPR and Cas Genes Market, by Product and Service, 2018 - 2030 (USD Million)
  • Table 58 Brazil CRISPR and Cas Genes Market, by Application, 2018 - 2030 (USD Million)
  • Table 59 Brazil CRISPR and Cas Genes Market, by End-use, 2018 - 2030 (USD Million)
  • Table 60 Mexico CRISPR and Cas Genes Market, by Product and Service, 2018 - 2030 (USD Million)
  • Table 61 Mexico CRISPR and Cas Genes Market, by Application, 2018 - 2030 (USD Million)
  • Table 62 Mexico CRISPR and Cas Genes Market, by End-use, 2018 - 2030 (USD Million)
  • Table 63 Argentina CRISPR and Cas Genes Market, by Product and Service, 2018 - 2030 (USD Million)
  • Table 64 Argentina CRISPR and Cas Genes Market, by Application, 2018 - 2030 (USD Million)
  • Table 65 Argentina CRISPR and Cas Genes Market, by End-use, 2018 - 2030 (USD Million)
  • Table 66 Middle East and Africa CRISPR and Cas Genes Market, by Country, 2018 - 2030 (USD Million)
  • Table 67 Middle East and Africa CRISPR and Cas Genes Market, by Product and Service, 2018 - 2030 (USD Million)
  • Table 68 Middle East and Africa CRISPR and Cas Genes Market, by Application, 2018 - 2030 (USD Million)
  • Table 69 Middle East and Africa CRISPR and Cas Genes Market, by End-use, 2018 - 2030 (USD Million)
  • Table 70 South Africa CRISPR and Cas Genes Market, by Product and Service, 2018 - 2030 (USD Million)
  • Table 71 South Africa CRISPR and Cas Genes Market, by Application, 2018 - 2030 (USD Million)
  • Table 72 South Africa CRISPR and Cas Genes Market, by End-use, 2018 - 2030 (USD Million)
  • Table 73 Saudi Arabia CRISPR and Cas Genes Market, by Product and Service, 2018 - 2030 (USD Million)
  • Table 74 Saudi Arabia CRISPR and Cas Genes Market, by Application, 2018 - 2030 (USD Million)
  • Table 75 Saudi Arabia CRISPR and Cas Genes Market, by End-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Information Procurement
  • Fig. 2 Primary Research Pattern
  • Fig. 3 Market Research Approaches
  • Fig. 4 Value Chain-Based Sizing & Forecasting
  • Fig. 5 Market Formulation & Validation
  • Fig. 6 CRISPR and Cas genes, Market Segmentation
  • Fig. 7 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 8 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 9 Market Challenge Relevance Analysis (Current & Future Impact)
  • Fig. 10 Penetration & Growth Prospect Mapping
  • Fig. 11 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 12 Porter's Five Forces Analysis
  • Fig. 13 Market Penetration Vs Growth Prospect Mapping, 2021
  • Fig. 14 Regional Marketplace: Key Takeaways
  • Fig. 15 Global CRISPR and Cas genes Market, for Product, 2018 - 2030 (USD Million)
  • Fig. 16 Global CRISPR and Cas genes Market, for Kits & Enzymes, 2018 - 2030 (USD Million)
  • Fig. 17 Global CRISPR and Cas genes Market, for Vector-based Cas9 2018 - 2030 (USD Million)
  • Fig. 18 Global CRISPR and Cas genes Market, for DNA-free Cas9 2018 - 2030 (USD Million)
  • Fig. 19 Global CRISPR and Cas genes Market, for Libraries, 2018 - 2030 (USD Million)
  • Fig. 20 Global CRISPR and Cas genes Market, for Design Tool, 2018 - 2030 (USD Million)
  • Fig. 21 Global CRISPR and Cas genes Market, for Antibodies , 2018 - 2030 (USD Million)
  • Fig. 22 Global CRISPR and Cas genes Market, for Others , 2018 - 2030 (USD Million)
  • Fig. 23 Global CRISPR and Cas genes Market, for Service, 2018 - 2030 (USD Million)
  • Fig. 24 Global CRISPR and Cas genes Market, for Cell Line Engineering , 2018 - 2030 (USD Million)
  • Fig. 25 Global CRISPR and Cas genes Market, for gRNA Design , 2018 - 2030 (USD Million)
  • Fig. 26 Global CRISPR and Cas genes Market, for Microbial Gene Editing , 2018 - 2030 (USD Million)
  • Fig. 27 Global CRISPR and Cas genes Market, for DNA synthesis , 2018 - 2030 (USD Million)
  • Fig. 28 Global CRISPR and Cas genes Market, for Biomedical , 2018 - 2030 (USD Million)
  • Fig. 29 Global CRISPR and Cas genes Market, for Genome Engineering, 2018 - 2030 (USD Million)
  • Fig. 30 Global CRISPR and Cas genes Market, for Disease Model Studies, 2018 - 2030 (USD Million)
  • Fig. 31 Global CRISPR and Cas genes Market, for Functional Genomics , 2018 - 2030 (USD Million)
  • Fig. 32 Global CRISPR and Cas genes Market, for Epigenetics, 2018 - 2030 (USD Million)
  • Fig. 33 Global CRISPR and Cas genes Market, for Others , 2018 - 2030 (USD Million)
  • Fig. 34 Global CRISPR and Cas genes Market, for Agricultural , 2018 - 2030 (USD Million)
  • Fig. 35 Global CRISPR and Cas genes Market, for Biotechnology & Pharmaceutical Companies, 2018 - 2030 (USD Million)
  • Fig. 36 Global CRISPR and Cas genes Market, for Academics & Government Research Institutes, 2018 - 2030 (USD Million)
  • Fig. 37 Global CRISPR and Cas genes Market, for Contract Research Organizations (CROs), 2018 - 2030 (USD Million)
  • Fig. 38 Regional Outlook, 2021 & 2030
  • Fig. 39 North America CRISPR and Cas genes Market, 2018 - 2030 (USD Million)
  • Fig. 40 U.S. CRISPR and Cas genes Market, 2018 - 2030 (USD Million)
  • Fig. 41 Canada CRISPR and Cas genes Market, 2018 - 2030 (USD Million)
  • Fig. 42 Europe CRISPR and Cas genes Market, 2018 - 2030 (USD Million)
  • Fig. 43 Germany CRISPR and Cas genes Market, 2018 - 2030 (USD Million)
  • Fig. 44 U.K. CRISPR and Cas genes Market, 2018 - 2030 (USD Million)
  • Fig. 45 France CRISPR and Cas genes Market, 2018 - 2030 (USD Million)
  • Fig. 46 Italy CRISPR and Cas genes Market, 2018 - 2030 (USD Million)
  • Fig. 47 Spain CRISPR and Cas genes Market, 2018 - 2030 (USD Million)
  • Fig. 48 Asia Pacific CRISPR and Cas genes Market, 2018 - 2030 (USD Million)
  • Fig. 49 Japan CRISPR and Cas genes Market, 2018 - 2030 (USD Million)
  • Fig. 50 China CRISPR and Cas genes Market, 2018 - 2030 (USD Million)
  • Fig. 51 India CRISPR and Cas genes Market, 2018 - 2030 (USD Million)
  • Fig. 52 Latin America CRISPR and Cas genes Market, 2018 - 2030 (USD Million)
  • Fig. 53 Brazil CRISPR and Cas genes Market, 2018 - 2030 (USD Million)
  • Fig. 54 Mexico CRISPR and Cas genes Market, 2018 - 2030 (USD Million)
  • Fig. 55 Middle East and Africa CRISPR and Cas genes Market, 2018 - 2030 (USD Million)
  • Fig. 56 South Africa CRISPR and Cas genes Market, 2018 - 2030 (USD Million)
  • Fig. 57 Saudi Arabia CRISPR and Cas genes Market, 2018 - 2030 (USD Million)